| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-06-30 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $36.32K | $577.00 | $0.00 | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $428.41K | $309.40K | $249.15K | $61.10K | $19.18K | $28.72K |
| R&D | – | – | – | – | – | – |
| SG&A | $158.33K | $17.08K | $7.71K | $61.10K | $19.18K | $28.72K |
| Operating Income | -$392.09K | -$308.83K | -$249.15K | -$61.10K | – | – |
| Interest Expense | $316.12K | $236.46K | $111.96K | $0.00 | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$692.96K | -$539.04K | -$356.48K | -$61.10K | -$19.18K | -$28.72K |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | -0.0200 | -0.0100 | – | – | – | – |
| Shares (diluted) | $36.91M | $40.83M | $44.49M | – | – | – |